Search research articles
Contact Us
Filters
Showing results (81-90 of 99) with videos related to
Page
of 10
Sort By:
Microbiology Spectrum
|
May 22, 2025
Evaluation of the role of <i>whiB6</i> and <i>kdpDE</i> in the dominant multidrug-resistant clone <i>Mycobacterium tuberculosis</i> B0/W148
Isabelle Bonnet, Mickael Orgeur, Florence Brossier, et al.
International Journal of Antimicrobial Agents
|
February 12, 2019
Use of non-carbapenem antibiotics to treat severe extended-spectrum β-lactamase-producing Enterobacteriaceae infections in intensive care unit patients
Charles-Edouard Luyt, Morgane Faure, Isabelle Bonnet, et al.
Critical Care (London, England)
|
August 20, 2018
Predictors of insufficient peak amikacin concentration in critically ill patients on extracorporeal membrane oxygenation
Cyril Touchard, Alexandra Aubry, Philippine Eloy, et al.
Antimicrobial Agents and Chemotherapy
|
December 18, 2013
Imipenem, meropenem, or doripenem to treat patients with Pseudomonas aeruginosa ventilator-associated pneumonia
Charles-Edouard Luyt, Alexandra Aubry, Qin Lu, et al.
The Lancet Regional Health. Europe
|
December 1, 2025
Diagnostic algorithms for tuberculosis in Europe: insights from the European Reference Laboratory Network for Tuberculosis (ERLTB-Net)
Francesca Saluzzo, Andrea Maurizio Cabibbe, Richard Anthony, et al.
Annals of Clinical Microbiology and Antimicrobials
|
May 7, 2016
Evaluation of the SLOMYCO Sensititre(®) panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates
Marion Chazel, Hélène Marchandin, Nicolas Keck, et al.
Biorxiv : the Preprint Server for Biology
|
July 3, 2026
Assessing <i>Corynebacterium glutamicum</i> as a surrogate of <i>Mycobacterium tuberculosis</i> for DNA gyrase inhibitor design
Yaëlle Wormser, Emilie Yab, Adrià Sogues, et al.
NPJ Drug Discovery
|
April 7, 2025
Structural and mechanistic study of a novel inhibitor analogue of <i>M. tuberculosis</i> cytochrome bc<sub>1</sub>:aa<sub>3</sub>
Amit K Verma, Robbert Q Kim, Dirk A Lamprecht, et al.
Emerging Infectious Diseases
|
March 2, 2025
Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment
Valentina Gerussi, Tania Petersen, Isabelle Bonnet, et al.
Nature Communications
|
May 11, 2026
Direct carbapenemase typing from disc diffusion antibiograms with MALCA (MAchine Learning CArbapenemase)
Cécile Emeraud, Yahia Benzerara, Hippolyte De Swardt, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 99) with videos related to
Sort By:
Page
of 10
Microbiology Spectrum
|
May 22, 2025
Evaluation of the role of <i>whiB6</i> and <i>kdpDE</i> in the dominant multidrug-resistant clone <i>Mycobacterium tuberculosis</i> B0/W148
Isabelle Bonnet, Mickael Orgeur, Florence Brossier, et al.
International Journal of Antimicrobial Agents
|
February 12, 2019
Use of non-carbapenem antibiotics to treat severe extended-spectrum β-lactamase-producing Enterobacteriaceae infections in intensive care unit patients
Charles-Edouard Luyt, Morgane Faure, Isabelle Bonnet, et al.
Critical Care (London, England)
|
August 20, 2018
Predictors of insufficient peak amikacin concentration in critically ill patients on extracorporeal membrane oxygenation
Cyril Touchard, Alexandra Aubry, Philippine Eloy, et al.
Antimicrobial Agents and Chemotherapy
|
December 18, 2013
Imipenem, meropenem, or doripenem to treat patients with Pseudomonas aeruginosa ventilator-associated pneumonia
Charles-Edouard Luyt, Alexandra Aubry, Qin Lu, et al.
The Lancet Regional Health. Europe
|
December 1, 2025
Diagnostic algorithms for tuberculosis in Europe: insights from the European Reference Laboratory Network for Tuberculosis (ERLTB-Net)
Francesca Saluzzo, Andrea Maurizio Cabibbe, Richard Anthony, et al.
Annals of Clinical Microbiology and Antimicrobials
|
May 7, 2016
Evaluation of the SLOMYCO Sensititre(®) panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates
Marion Chazel, Hélène Marchandin, Nicolas Keck, et al.
Biorxiv : the Preprint Server for Biology
|
July 3, 2026
Assessing <i>Corynebacterium glutamicum</i> as a surrogate of <i>Mycobacterium tuberculosis</i> for DNA gyrase inhibitor design
Yaëlle Wormser, Emilie Yab, Adrià Sogues, et al.
NPJ Drug Discovery
|
April 7, 2025
Structural and mechanistic study of a novel inhibitor analogue of <i>M. tuberculosis</i> cytochrome bc<sub>1</sub>:aa<sub>3</sub>
Amit K Verma, Robbert Q Kim, Dirk A Lamprecht, et al.
Emerging Infectious Diseases
|
March 2, 2025
Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment
Valentina Gerussi, Tania Petersen, Isabelle Bonnet, et al.
Nature Communications
|
May 11, 2026
Direct carbapenemase typing from disc diffusion antibiograms with MALCA (MAchine Learning CArbapenemase)
Cécile Emeraud, Yahia Benzerara, Hippolyte De Swardt, et al.
Page
of 10